Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue in Cirrhotic Patients with Refractory Septic Shock
NCT03120637Phase 4Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylene blue in septic shock, Vasoplegia, sponsored by Institute of Liver and Biliary Sciences. Started Jan 2017; status: completed.
02
Drugs
methylene blue
03
Conditions
septic shockVasoplegia
Beyond the preview
Go deeper on NCT03120637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120637.